Skip to content

Clinical trials

Completed Observational Adenocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Observational Status: Completed Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20051
20062
20072
20103
20114
20122
20131
20144
20161
20172
20182
20191
20202
20211
20223
20233
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic3
Stanford University3
Memorial Sloan Kettering Cancer Center2
St. James's Hospital, Ireland2
University Hospital, Bordeaux2
Alanya Alaaddin Keykubat University1
AstraZeneca1
Boston Scientific Corporation1
Clinica Universidad de Navarra, Universidad de Navarra1
Cook Research Incorporated1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma41
Prostatic Neoplasms11
Carcinoma9
Carcinoma, Squamous Cell8
Esophageal Neoplasms6
Neoplasms6
Lung Neoplasms5
Neoplasm Metastasis5
Carcinoma, Non-Small-Cell Lung4
Pancreatic Neoplasms4

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.